Nektar Therapeutics v. Quadrant Drug Delivery Ltd.
310 F. App'x 383
This text of 310 F. App'x 383 (Nektar Therapeutics v. Quadrant Drug Delivery Ltd.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Nektar Therapeutics v. Quadrant Drug Delivery Ltd., 310 F. App'x 383 (Fed. Cir. 2008).
Opinion
ON MOTION
ORDER
Nektar Therapeutics moves to voluntarily dismiss its appeal.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) Nektar Therapeutics’s motion is granted. The appeal is dismissed.
(2) Each side shall bear its own costs.
(3) All pending motions are moot.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
310 F. App'x 383, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nektar-therapeutics-v-quadrant-drug-delivery-ltd-cafc-2008.